Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PET, MRR

India Veterinary Hypodermic Syringes and Needles Market Report 2023: Market to Grow at a CAGR of 8.8% to 2029 - Key Insights into Product, Animal Type, Dosage, and End Users


DUBLIN, Dec. 12, 2023 /PRNewswire/ -- The "India Veterinary Hypodermic Syringes and Needles Market 2023-2029: Market Forecast By Product, By Animal Type, By Dosage, By End Users, By Regions and Competitive Landscape" report has been added to  ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

India Veterinary Hypodermic Syringes and Needles market revenue size is projected to grow at a CAGR of 8.8% during 2023-2029

Attributed to increasing pet adoption in India along with a significantly growing allocation of funds in animal healthcare under various schemes and programs. For instance, the Department of Animal Husbandry allocated 2,349 INR Crores in animal healthcare under Livestock Health and Disease Control Program in FY 2023-24 witnessing an increase of 69% in the allocation amount from the previous fiscal year.

This amount will be used to expand the accessibility of veterinary services owing to which, demand for veterinary hypodermic syringes and needles is expected to augment during the forecast period.

In 2020, the sudden outburst of the COVID-19 pandemic adversely affected the growth of the India Veterinary Hypodermic Syringes and Needles market, and the demand for veterinary hypodermic syringes and needles plunged owing to government imposed nationwide lockdown in addition to disruption in the supply chain that led to the halt in operations of manufacturing industries which resulted in the contraction of the economy and an increasing death toll of people owing to pandemic shifted the government funding towards vaccination of citizens across the country which further restricted growth of the market.

India Veterinary Hypodermic Syringes & Needles Market Synopsis

India Veterinary Hypodermic Syringes and Needles market is anticipated to witness significant growth during the forecast period, on the back of initiatives such as the Livestock Health and Disease Control Program, National Animal Disease Control Program, and others by the Government of India.

These initiatives are aimed to fund animal immunization programs, improving veterinary infrastructure, and preventing from widely spreading animal diseases such as Foot and Mouth Disease (FMD) and Brucellosis. Such initiatives are aiding the expansion of veterinary facilities through the introduction of mobile veterinary vans, ambulances, and clinics across India which would directly expand the accessibility of veterinary services providing impetus to the demand for veterinary hypodermic syringes and needles in the India Veterinary Hypodermic Syringes and Needles Industry during the forecast period.

Market by Product

Syringes account for a major revenue share in India veterinary needle and syringes market as syringes have a superior average selling price than needles. However, needle acquires a higher volume share due to single usage, syringe on the other hand are sometimes used multiple times.

Market by Animal Type

In 2022, Bovine Animal generated the major revenue share in India Veterinary Hypodermic Syringes and Needles Market as the government implemented various programs and initiatives to improve the healthcare and productivity of bovine animals such as the National Animal Disease Control Program, National Kamdhenu Breeding Center, Integrated Dairy Development Scheme, which has increased the distribution and use of medical supplies such as hypodermic needle and syringes. Thus, contributed to the growth of the segment.

Market by Dosage

Variable Dosage garnered the major revenue share in India Veterinary Hypodermic Syringes and Needles Market due to the increased adoption of variable dosage syringes, which provide greater flexibility in administering medications. Additionally, their ability to accommodate various animal sizes and administer different medications by adjusting the dosage, eliminates the necessity to purchase multiple syringe sizes. This cost-effective solution is highly favored by veterinarians, thereby driving the growth of the variable dosage segment.

Market by End Users

Veterinary hospitals accounted for the majority market share in the India Veterinary Hypodermic Syringes and Needles Market as pet and livestock owners prefer hospitals over other facilities owing to their ability to provide a comprehensive approach to animal healthcare.

Additionally, many government and private hospitals are expanding their service in India to provide better healthcare to animals. For Instance, In August 2022, DCC (Dogs Cats & Companions) Animal Hospital, one of India's leading multi-specialty pet care chains expanded with a new full-service medical center in Delhi, which contributed to the growth of the segment.

Market by Regions

North region emerged as a major shareholder in the market in 2022, as it has a major livestock population owing to agricultural dominance which has augmented the demand for veterinary hypodermic needles and syringes in the region.

Moreover, the segment is expected to witness a surge in demand on account of increasing government initiatives and regional developments. For instance, the Government of Himachal Pradesh has launched "Project Sanjeevani" which will provide veterinary services at the doorstep of the farmers.

Key Highlights of the Report

Company Profiles

Market Scope and Segmentation

By Product

By Animal Type

By Dosage

By End Users

By Regions

For more information about this report visit https://www.researchandmarkets.com/r/hbzohf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

15 mai 2024
Full year 2023 revenue of $90.9 million compared to $99.4 million in 2022, and $90.5 million compared to $86.7 million on a normalized basis, excluding one-time COVID mandates.Q4 2023 gross profit margin1 of 39.7% was relatively flat compared to Q3...

15 mai 2024
Record Operating Revenues and Net Income: DeFi Technologies recorded its strongest quarter ever, achieving Operating Revenues of C$13.4 million and Operating Net Income of C$5.3 million for Q1 2024.Strategic Advancements and Product Launches: The...

15 mai 2024
Mace Security International today announced its first quarter 2024 financial results for the period ended March 31, 2024.The Company's net sales for the first quarter of 2024 were $1,357,000, down (18%) versus the like period in 2023. The decrease...

15 mai 2024
As the nation continues to emerge from the recession brought on by the 2020 COVID-19 pandemic, a new report on youth employment, Uneven Recovery and Sustained Inequality after the COVID-19 Recession: Employment for Chicago's Youth and Young Adults,...

15 mai 2024
The Parliamentary Assembly of the Mediterranean (PAM) has announced the recipient of the inaugural PAM Global Humanitarian Personality Award at the 18th Plenary Session held in Braga, Portugal. For the first time, this prestigious recognition is...

15 mai 2024
Retractable Technologies, Inc. reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period last year of $11.0 million and...



News published on and distributed by: